FDA no longer requiring significant warning label with hormone therapies for menopause

The removal of warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms is a major turnaround that's likely to encourage more women to seek treatment. Dr. Cindy Long, OBGYN from HCA HealthONE Women's Health Group, visits with CBS News Colorado about the announcement.

Watch the CBS News Colorado segment

Learn more about Dr. Long and the team at HCA HealthONE Women's Health Group